Retatrutide is a triple hormone receptor agonist that affects GLP-1, GIP, and glucagon receptors, while other medications may target one or two pathways
Despite the proven effectiveness of GLP-1s, adherence remains a major challenge, with only 32% of patients continuing treatment after one year
By helping to increase the production of red blood cells, vitamin B12 may improve oxygen delivery to the muscles during exercise
Semaglutide has a half-life of approximately 7 days (Lau et al., Clinical Pharmacokinetics 2015)
After age 70, women on hormones face a higher risk of blood clots, stroke, and heart disease, and hormone therapy seems to increase these risks, Santoro said